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Abstract: Respiratory failure in patients with COPD may be caused by insufﬁ  cient force 
production or insufﬁ  cient endurance capacity of the respiratory muscles. Anabolic steroids may 
improve respiratory muscle function in COPD. The effect of anabolic steroids on mitochondrial 
function in the diaphragm in emphysema is unknown. In an emphysematous male hamster 
model, we investigated whether administration of the anabolic steroid nandrolone decanoate 
(ND) altered the activity of mitochondrial respiratory chain complexes in the diaphragm. The 
bodyweight of hamsters treated with ND was decreased after treatment compared with initial 
values, and serum testosterone levels were signiﬁ  cantly lower in hamsters treated with ND than 
in control hamsters. No difference in the activity of mitochondrial respiratory chain complexes 
in the diaphragm between normal and emphysematous hamsters was observed. Treatment with 
ND did not change the activity of mitochondrial respiratory chain complexes in the diaphragm 
of both normal and emphysematous hamsters. In emphysematous hamsters, administration 
of ND decreased the activity of succinate:cytochrome c oxidoreductase compared with ND 
treatment in normal hamsters. We conclude that anabolic steroids have negative effects on the 
activity of succinate:cytochrome c oxidoreductase and anabolic status in this emphysematous 
hamster model.
Keywords: emphysema, diaphragm, mitochondria, anabolic steroids
Introduction
In patients with COPD, the diaphragm is chronically overloaded, which is more serious 
with increasing severity of the disorder. As a result, several adaptations occur, including 
a shift from fast, glycolytic, type II ﬁ  bers to slow, oxidative, type I ﬁ  bers (Levine et al 
1997; Mercadier et al 1998). Furthermore, metabolic changes occur, resembling those 
that emerge after endurance training, such as an increase in oxidative capacity (Noble 
and Ianuzzo 1985; Green et al 1995; Proctor et al 1995). Mitochondrial function is 
enhanced in the diaphragm of patients with COPD (Ribera et al 2002), as indicated 
by increases in the maximum rate of mitochondrial respiration and efﬁ  ciency of the 
mitochondrial electron transport chain. This is considered to be beneﬁ  cial, because 
these changes cause an increase in endurance capacity.
Despite this shift towards a more fatigue-resistant muscle, the majority of patients 
with severe COPD die from respiratory failure (Braghiroli et al 1997). This respira-
tory failure may have multiple causes, including insufﬁ  cient force production or 
insufﬁ  cient endurance capacity of the respiratory muscles, or a combination of these 
factors. For example, Levine et al (2003) observed reduced force-generating capacity 
in the diaphragm of COPD patients. 
Anabolic steroids may be helpful in preventing respiratory failure. Clinical studies 
have mainly investigated the effect of treatment with anabolic steroids on muscle 
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force-generating capacity. For example, it has been shown 
that treatment with nandrolone decanoate (ND) improved 
respiratory muscle function and exercise capacity after a 
pulmonary rehabilitation program in COPD patients using 
oral glucocorticosteroids (Creutzberg et al 2003). Treat-
ment with testosterone resulted in increases in quadriceps 
muscle strength and endurance with and without a resistance 
training program in COPD patients (Casaburi et al 2004). In 
this study, testosterone did not change respiratory muscle 
strength.
In animal models, the effects of anabolic steroid treat-
ment on oxidative capacity in several skeletal muscles have 
been investigated. Controversy exists in the literature about 
the effect of anabolic steroids on mitochondrial function and 
associated endurance capacity. The effect of anabolic steroids 
on mitochondrial function seems to be dependent on ﬁ  ber 
type, with fast-twitch ﬁ  bers (Saborido et al 1991) or aerobic 
muscle (Egginton 1987) being most sensitive to an increase 
in oxidative capacity in rats. 
For preventing respiratory failure, it is important to 
know if treatment with anabolic steroids results in increased 
respiratory muscle oxidative capacity and mitochondrial 
function, especially in emphysema. Therefore, we investi-
gated whether administration of ND increased the activity of 
mitochondrial respiratory chain complexes in the diaphragm 
of emphysematous hamsters. For this purpose, we treated 
healthy and emphysematous hamsters with ND or placebo 
and determined the activity of several parts of the mitochon-
drial energy-generating system.
Methods 
Animals
Male 40-week-old inbred Syrian golden hamsters (Elevage 
Janvier) with initial bodyweight ~100 g were used. The 
animals were randomly divided into normal (NH) and em-
physematous (EH) groups. The study was approved by the 
Animal Experiments Committee of the University Medical 
Centre Nijmegen and performed according to the Dutch 
National Guidelines of Animal Care.
Induction of emphysema
Under anesthesia of a mixture of 2.5% isoﬂ  urane and N2O and 
O2 (1:2), saline (NH) or porcine pancreatic elastase (18 U/100 g 
bodyweight [Raub et al 1982] [EPC, Owensville, MI, USA] 
in 0.50 mL normal saline) was instilled intratracheally, as 
described in detail previously (Lewis et al 1992; van der 
Heijden et al 1998; van Balkom et al 1999).
Determination of degree of emphysema
When the animals were killed the lungs were removed for 
measurement of the lung volume by ﬂ  uid displacement to 
evaluate the extent of emphysema.
Anabolic steroid administration
Fifty-two weeks after induction of emphysema, the normal 
hamsters and emphysematous hamsters were divided into 
treated (ND) and nontreated (CON) groups. Hamsters in 
the treated groups were injected for 10 weeks with 2.5 mg/kg 
ND (Deca-Durabolin, NV Organon, Oss, The Netherlands) 
once a week intramuscularly. To obtain maximum effect, ND 
was administered in the maximum dose as recommended by 
the manufacturer for use in patients. Hamsters in the control 
groups were injected with saline for the same period. Groups 
were subdivided as follows: NH CON (n=9), EH CON 
(n=12), NH ND (n=10), and EH ND (n=14).
General procedures
Sixty-two weeks after instillation the hamsters were anesthe-
tized with pentobarbital sodium (Nembutal, 70 mg/kg intra-
peritoneally). A polyethylene cannula was inserted through 
a tracheotomy for mechanical ventilation with 100% O2. The 
diaphragm was quickly excised after combined laparotomy 
and thoracotomy and put immediately in ice-cold SETH 
buffer (0.25 mol/L sucrose, 2 mmol/L EDTA, 10 mmol/L Tris, 
5 × 104 U heparin, pH 7.4).
Mitochondrial function
Homogenization procedure of muscle tissue
Diaphragm muscle was washed with fresh ice-cold SETH, 
and fat and connective tissue were disconnected. Tissue 
was cut in very small pieces of about 0.1 × 0.1 mm with 
the aid of a Sorvall TC2 tissue chopper with razor blade. 
Tissue was homogenized in fresh ice-cold SETH buffer 
(5%–10% w/v) with a Potter Elvehjem tissue homogenizer 
according to Fischer, Ruitenbeek, Stadhouders, et al 
(1985). Some100-μL samples of the crude homogenate 
were frozen immediately in liquid nitrogen and kept 
at –80°C for measuring protein content, cytochrome c 
oxidase and citrate synthase (CS). The rest of the crude 
homogenate was centrifuged for 10 minutes at 2°C at 
600 × g. The 600 × g supernatant was frozen in 100-μL 
aliquots in liquid nitrogen and kept at –80°C for measuring 
protein content, CS activity, and activities of respiratory 
chain enzymes. CS activity was measured according to 
Srere (1969) with minor modifications. Briefly, a sample International Journal of COPD 2006:1(1) 85
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of the 600  × g supernatant was diluted (1:1) with SETH 
buffer containing 0.5% Triton X-100. A 50-μL sample 
was incubated in a total volume of 1.0 mL containing 
0.1 mol/L Tris, 0.1 mmol/L DTNB (5,5′-dithio bis(2-nitro)-
benzoate), 0.3 mmol/L acetylcoenzyme-A, and 0.5 mmol/L 
oxaloacetic acid, pH 8.1. In the blank, oxaloacetic acid 
was omitted. Coenzyme-A production by CS was measured 
spectrophotometrically at 412  nm by measuring the 
reduction of DTNB. Protein concentration was measured 
according to Lowry et al (1951) with minor modifications.
Incubations
Incubations for determination of the activity of succinate:
cytochrome c oxidoreductase (SCC) were performed accord-
ing to Fischer, Ruitenbeek, Berden, et al (1985) with minor 
modiﬁ  cations. Incubations for determination of complex III 
(C-III) and complex IV (C-IV) activity were performed 
according to Bentlage et al (1996) and Cooperstein and 
Lazarow (1951), respectively. Activities of SCC, C-III, and 
C-IV were divided by CS activity for correction for mito-
chondrial content.
Serum testosterone levels
When the animals were killed, blood samples were taken 
from the abdominal aorta for serum testosterone concen-
tration measurements. Serum testosterone was assessed 
by a 3H-radioimmunoassay (RIA) after prepuriﬁ  cation by 
means of paper chromatography of ether extracts of the 
samples, including correction for procedural losses, as 
described previously (Swinkels et al 1987). To summarize 
brieﬂ  y, before extraction 3H-testosterone was added to 
correct for procedural losses. After chroma-tography, 
radio chromatogram scanning identiﬁ  ed the location of the 
testosterone zone; the zone was cut out and soaked in buffer. 
The recovered radioactivity was measured by liquid scintil-
lation counting of an aliquot from the eluate. Subsequently, 
testosterone tracer and antiserum were added, and after 
incubation, free and bound tracers were separated by means 
of dextrane-coated charcoal. The antibody-bound radioac-
tivity was assessed by liquid scintillation counting of the 
supernatant. The calculations were performed by special 
software designed for correction of the mass and radioactive 
contribution of the recovery tracer in the RIA. The detection 
limit was 3.5 pmol/L.
Statistical analysis
Data are presented as mean ± standard error of the mean 
(SEM) when appropriate. Data were analyzed with SPSS 
for Windows, version 12.0.1 (SPSS, Chicago, IL, USA). 
A one-way ANOVA (analysis of variance) test and a Tukey 
post hoc test were used to determine if there were differences 
between the groups. A paired t test was used to determine 
differences within the groups before and after treatment. 
Signiﬁ  cance was set at the 0.05 level.
Results
Bodyweight
Bodyweight was signiﬁ  cantly lower in both emphyse-
matous hamster groups than in normal groups before 
treatment (p < 0.05). After treatment, bodyweight was 
significantly lower in the normal nandrolone-treated 
hamster group and the emphysematous nandrolone-treated 
group than before treatment (p < 0.05). The results are 
shown in Table 1.
Degree of emphysema
Mean lung volume was significantly higher in the 
emphysematous hamster groups than in the normal groups 
(17.0 ± 0.5 mL vs 11.4 ± 0.5 mL; p < 0.001), indicating that in 
the emphysematous groups emphysema was indeed induced. 
Furthermore, lung volume was higher in emphysematous 
nandrolone-treated than emphysematous control hamsters 
(p = 0.004). Lung volumes are presented in Table 1.
Serum testosterone levels
Serum testosterone levels were equal in emphysematous 
and normal hamsters. After treatment with ND, serum 
testosterone levels in normal nandrolone-treated hamsters 
were signiﬁ  cantly decreased compared with those of normal 
control hamsters and in emphysematous nandrolone-treated 
hamsters compared with emphysematous controls (p = 0.001 
and p < 0.001, respectively). Serum testosterone levels are 
presented in Figure 1.
Table 1 Bodyweights and lung volumes (mean ± SEM)
  NH CON   EH CON  NH ND   EH ND 
  (n = 9)   (n = 12)  (n = 10)  (n = 14)
Initial bodyweight (g)  141 ± 5  127 ± 4a  146 ± 3  131 ± 3a
Final bodyweight (g)  144 ± 6  129 ± 4  140 ± 3b  121 ± 3b
Lung volume (mL)  10.9 ± 0.5   15.7 ± 1.8c  12.2 ± 0.8  18.3 ± 2.6c, d
a p < 0.05 EH vs NH. 
b p < 0.05 before vs after treatment.
c p < 0.001 EH vs NH.
d p < 0.01 EH ND vs EH CON.
Abbreviations: CON, control group; EH, emphysematous hamster; 
NH, normal hamster; ND, nandrolone group.International Journal of COPD 2006:1(1) 86
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Mitochondrial function
The activity of CS, C-III, and C-IV was equal between the 
four treatment groups. The activity of SCC was not differ-
ent between normal control hamsters and emphysematous 
controls. However, after treatment with ND, the activity of 
SCC was signiﬁ  cantly higher in the diaphragm of normal 
hamsters than in that of emphysematous animals. The mito-
chondrial function results are presented in Figures 2–5.
Discussion
This is the ﬁ  rst study to investigate the effects of treatment 
with an anabolic steroid on the activity of mitochondrial 
respiratory chain complexes in the diaphragm of 
emphysematous hamsters. It shows that the activity of 
mitochondrial respiratory chain complexes in the diaphragm 
was not different between normal and emphysematous 
hamsters. Treatment with ND did not change the activity of 
mitochondrial respiratory chain complexes in either normal 
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Figure 1 Serum testosterone concentration.
a p < 0.05 vs NH CON group.
b p < 0.05 vs EH CON group.
Abbreviations Figures 1–5: NH, normal hamster; EH, emphysematous hamster; 
CON, control group; ND, nandrolone group. 
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Figure 2  Activity of citrate synthase (CS) in the diaphragm. 
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Figure 3  Activity of succinate: cytochrome c oxidoreductase (SCC) in the 
diaphragm.
a p < 0.05 vs NH ND group.
8000
6000
4000
2000
0
NH CON
C
-
I
I
I
 
a
c
t
i
v
i
t
y
 
(
 
m
U
/
U
/
U
 
C
S
)
EH CON NH ND EH ND
Figure 4  Activity of complex III (C-III) in the diaphragm. 
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Figure 5  Activity of complex IV (C-IV) in the diaphragm. International Journal of COPD 2006:1(1) 87
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or emphysematous hamsters. However, in emphysematous 
animals ND treatment decreased the activity of SCC com-
pared with ND treatment in normal hamsters. Mitochondrial 
content was not changed after ND treatment. Furthermore, 
bodyweight of hamsters treated with ND was decreased after 
treatment compared with initial values, and serum testoster-
one levels were signiﬁ  cantly lower in animals treated with 
ND than in controls.
In mitochondria, energy is produced by the mitochondrial 
oxidative phosphorylation system, which is embedded in the 
mitochondrial inner membrane and comprises ﬁ  ve enzyme 
complexes (I–V) and two electron carriers (coenzyme Q 
and cytochrome c) (Hateﬁ   1985; Saraste 1999). The main 
function of the system is the coordinated transport of elec-
trons and protons through the different complexes, which 
leads to the production of adenosine triphosphate (ATP) 
(Smeitink et al 2001). This ATP can be used for diverse 
cell functions, including contractions in skeletal muscle. In 
our study, we found that mitochondrial energy-generating 
capacity of the diaphragm was not changed after treatment 
with anabolic steroids, either in normal or emphysematous 
hamsters. This is in agreement with the results of Saborido 
et al (1991), who found that in rat extensor digitorum longus 
(EDL), but not in soleus muscle, mitochondrial function was 
enhanced after treatment with ﬂ  uoxymesterone and meth-
androstanolone, suggesting a higher sensitivity for anabolic 
steroid in fast-twitch (EDL) muscle. In the same study, the 
number of mitochondria was not changed after administration 
of anabolic steroids. In contrast, Egginton (1987) suggested 
that aerobic muscles such as soleus and diaphragm are more 
susceptible to an increase of mitochondrial capacity after 
nandrolone phenylpropionate treatment. Beck and James 
(1978) showed an increase in mitochondrial volume in rat 
diaphragm after treatment with 19-nortestosterone. This is 
in agreement with the ﬁ  ndings of Satoh et al (2000), who 
found an increase in cross-sectional areas of mitochondria 
after treatment with nandrolone phenylpropionate in mouse 
diaphragm.
Comparison with previous results is difﬁ  cult, because 
different studies use different dose, species, duration of 
treatment, age, mode of administration, and activity level. 
These factors have been shown to inﬂ  uence the effects of 
anabolic treatment (Bresloff et al 1974; Beck and James 1978; 
Kopera 1985; Prezant et al 1993). For example, treatment of 
male rats with 19-nortestosterone in a low dose resulted in 
an increase in mitochondrial volume proportions in type I 
and intermediate ﬁ  bers, whereas treatment with a high dose 
resulted in a less marked increase in mitochondrial volume 
proportions, particularly in intermediate ﬁ  bers, suggesting 
that the response on anabolic steroids was lower in the 
high-dose group (Beck and James 1978). The variation in 
the abovementioned factors may explain the fact that the 
literature is very inconsistent about the effect of treatment 
with anabolic steroids on mitochondrial function.
Another finding in our study is that after treatment 
with ND, SCC activity per mitochondrion is decreased in 
the diaphragm of emphysematous compared with normal 
hamsters. SCC activity measures complexes II and III and 
the electron carrier coenzyme Q, which are located in the 
mitochondrial inner membrane (Molano et al 1999). Molano 
and colleagues reported decreased activity of enzymes in the 
mitochondrial inner membrane of rat liver after treatment 
with stanozolol and ﬂ  uoxymesterone, but no change in CS 
activity, which is located in the matrix space. The authors 
suggested that anabolic-androgenic steroids could affect the 
mitochondrial membrane owing to their hydrophobic nature. 
In the same study, no change in C-IV activity was found after 
treatment with stanozolol and ﬂ  uoxymesterone, suggesting 
that electron transport is disturbed in the electron transport 
chain before C-IV by these anabolic steroids (Molano et 
al 1999). However, in our study we did not ﬁ  nd a decrease 
in C-III activity after treatment with ND. This discrepancy 
in ﬁ  ndings may be due to the difference in tissue studied, 
namely hamster diaphragm in our study versus rat liver in the 
study of Molano and colleagues. Furthermore, in the latter 
study the anabolic steroids were administered orally, which 
produces a ﬁ  rst-pass effect in the liver, where the enzyme 
activities were measured. A possible explanation for our 
ﬁ  nding that SCC activity is decreased in the diaphragm of 
emphysematous hamsters treated with ND is that perhaps 
this speciﬁ  c mitochondrial part is more susceptible to the 
effects of ND administration in more active muscles (as is 
the diaphragm in emphysema).
It has recently been shown that the maximum rate of 
mitochondrial respiration and the efﬁ  ciency of the electron 
transport chain for ATP production are increased in the 
diaphragm of COPD patients (Ribera et al 2002). The maxi-
mum respiratory rate of the mitochondria in the diaphragm 
of COPD patients was twice as high as in the diaphragm of 
control subjects. Endurance training elicits an increase in 
maximum respiratory rate of the mitochondria in human 
vastus lateralis muscle (Walsh et al 2001). However, this 
increase is much less than that observed in the diaphragm 
of COPD patients (Ribera et al 2002). The respiratory rate International Journal of COPD 2006:1(1) 88
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is dependent on the muscle investigated in rats varying from 
9.6 μmol O2/min/g dry weight in soleus muscle to 32 μmol 
O2/min/g dry weight in cardiac muscle (De Sousa et al 2001). 
This rate also seems to be dependent on species, because 
the maximum mitochondrial respiration rate reported by 
Ribera et al (2002) in human diaphragm was 5.28 μmol 
O2/min/g dry weight, whereas the maximum respiration rate 
in rat diaphragm averaged 12 μmol O2/min/g dry weight (De 
Sousa et al 2001). Data on interventions eliciting changes 
in human diaphragmatic mitochondrial function are not 
available. Therefore, it can not be predicted if the increase in 
mitochondrial respiration as found by Ribera and colleagues 
could be augmented by an intervention.
The fact that in our study we did not ﬁ  nd an increase in 
the activity of mitochondrial respiratory chain complexes 
after ND treatment, either in normal or emphysematous 
hamsters, implies that treatment with ND may not increase 
the endurance capacity of the diaphragm. This suggests that 
treatment with anabolic steroids may not be able to prevent 
respiratory failure. However, respiratory failure may also be 
caused by a decrease in inspiratory muscle force-generating 
capacity. The role of anabolic steroids in preventing this cause 
of respiratory failure in patients with COPD is contradictory. 
For example, Creutzberg et al (2003) found an increase in 
maximum inspiratory muscle strength after ND treatment 
in COPD patients (50 mg ND/2 weeks). The patients in this 
study performed a pulmonary rehabilitation program consist-
ing of several endurance activities. Only in patients using oral 
glucocorticosteroids did ND treatment have an additional 
beneﬁ  cial effect on respiratory muscle function above the 
effect of pulmonary rehabilitation. This effect of ND was 
not observed in patients who did not use oral glucocorticos-
teroids. This is in accordance with the results of Casaburi 
et al (2004), who found no change in maximum inspiratory 
muscle strength after administration of testosterone in COPD 
patients who did not receive long-term oral corticosteroid 
treatment. The ﬁ  nding that in patients using corticosteroids 
ND treatment restores respiratory muscle function is in line 
with animal experimental studies (van Balkom et al 1998, 
1999). In a rat model, treatment with ND prevented the 
loss of diaphragm force induced by long-term, low-dose 
methylprednisolone administration (van Balkom et al 1998). 
A subsequent study (van Balkom et al 1999) reported that ND 
was also able to prevent the loss of diaphragmatic function in 
emphysematous hamsters treated with long-term, low-dose 
methylprednisolone. These ﬁ  ndings, combined with ﬁ  nd-
ings in the abovementioned studies (Creutzberg et al 2003; 
Casaburi et al 2004), suggest that treatment with anabolic 
steroids alone might be useful for preventing respiratory 
failure only in patients receiving corticosteroids.
In our study, we found that bodyweight was decreased 
after treatment with ND. This is in agreement with other 
studies, ﬁ  nding decreased bodyweight in male rats after treat-
ment with ND (Bisschop et al 1997). Circulating endogenic 
androgens may play a role. Surpassing the physiological 
level of androgens in males has been reported to result in 
depression of the natural production of testosterone (Ryan 
1981), downregulation of androgen-binding receptors 
(Rance and Max 1984), decrease in appetite (Kochakian and 
Endahl 1959), and a metabolic conversion to excess estradiol 
(Hickson and Kurowski 1986). The natural production of 
testosterone is indeed decreased in ND-treated hamsters in 
our study, which is shown by lower serum testosterone levels 
in the ND groups.
In conclusion, this study shows that the activity of 
mitochondrial respiratory chain complexes in the diaphragm 
in both normal and emphysematous hamsters was equal, 
and that treatment with ND did not change this activity. In 
emphysematous hamsters, administration of ND decreased 
the activity of SCC compared with ND treatment in normal 
hamsters. Furthermore, we have shown that bodyweight of 
hamsters treated with ND was decreased after treatment 
compared with initial values, and that treatment with ND 
resulted in signiﬁ  cantly lower serum testosterone levels 
in both normal and emphysematous hamsters. Taking all 
results together, our data do not support the use of anabolic 
steroids in preventing respiratory failure caused by fatigue 
of the diaphragm.
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